Reminder - The UK and much of Europe changed clocks to daylight saving over the weekend

ACHR's flying taxi dream: huge upside, but $0 revenue & $618M loss. Dilution risks loom.

GoodRx stock plunges 40.7% to $2.31. Negative ROIC & slow growth raise concerns despite cheap P/E.

Figma's stock jumps 5% post-board exit, but AI rivals loom. Anthropic's $800B valuation tests SaaS dominance.

ULS's 18.3% return is strong, but declining margins & ROIC at 40.6x P/E signal caution.

Skydance vows 30 films/yr post-$110B Warner Bros deal, but theater owners fear fewer releases.

IBP's 11.2% gain beats S&P 500. Strong EPS growth but revenue may stall. Trades at 25.8x P/E.

JNJ, ABT, BDX: Dividend Kings with recurring revenue offer defensive healthcare plays, outperforming in downturns despite litigation risks.